Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/6677 stock hub

TPEX/6677 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6677is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6677

In the news

Latest news · TPEX/6677

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-3.1

P25 -16.2P50 0.3P75 9.8

ROIC-3.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6677 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

TWD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	38%
Employees Change Percent	14.13
Enterprise value	TWD 1.5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006677008
Last refreshed	2026-05-10
Market cap	TWD 1.1B
Price	TWD 18.9
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6677
Website	https://www.anxo.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.23%
EV Earnings	-42.81x
EV/EBITDA	44.95x
EV/FCF	192.3x
EV/Sales	1.73x
FCF yield	0.72%
P/B ratio	0.95x
P/S ratio	1.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.18%
EBITDA Margin	3.86%
FCF margin	0.9%
Gross margin	35.6%
Gross Profit	TWD 300.2M
Gross Profit Growth	-0.23%
Gross Profit Growth Q	-0.54%
Gross Profit Growth3 Y	-6.47%
Gross Profit Growth5 Y	-0.41%
Net Income	TWD -34.1M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-5.41%
Profit Margin	-4.05%
ROA	-1.31
Roa5y	0.66
ROCE	-2.86
ROE	-3.13
Roe5y	1.02
ROIC	-3.15
Roic5y	0.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.18%
Cagr3y	-25.89%
Cagr5y	-6.1%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth5 Y	-12.73%
OCF Growth	74.58%
OCF Growth10 Y	3.43%
OCF Growth5 Y	-1.57%
Revenue Growth	-2.9x
Revenue Growth Q	-2.92x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.05x
Revenue Growth5 Y	0.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.4
Assets	TWD 2.1B
Cash	TWD 387.4M
Current Assets	TWD 823.9M
Current Liabilities	TWD 490.8M
Debt	TWD 676.4M
Debt EBITDA	TWD 20.8
Debt Equity	TWD 0.61
Debt FCF	TWD 89.01
Equity	TWD 1.1B
Interest Coverage	-2.63
Liabilities	TWD 958.7M
Long Term Assets	TWD 1.2B
Long Term Liabilities	TWD 467.9M
Net Cash	TWD -289M
Net Cash By Market Cap	TWD -27.37
Net Debt EBITDA	TWD 8.89
Net Debt Equity	TWD 0.26
Net Debt FCF	TWD 38.03
Tangible Book Value	TWD 947.3M
Tangible Book Value Per Share	TWD 16.9
WACC	4.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Inventory Turnover	2.1
Net Working Capital	TWD 202.7M
Quick ratio	1.07
Working Capital	TWD 308.5M
Working Capital Turnover	TWD 2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.25%
Dividend per share	TWD 0
Last Dividend	TWD 0.4

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.18%
200-day SMA	21.15
3Y total return	-59.31%
50-day SMA	19.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-26.99%
All Time High	77.2
All Time High Change	-75.52%
All Time High Date	2023-06-29
All Time Low	15.75
All Time Low Change	20%
All Time Low Date	2025-05-15
ATR	0.72
Beta	0.38
Beta1y	0.51
Beta2y	0.75
Ch YTD	0.8
High	19
High52	30.5
High52 Date	2025-10-01
High52ch	-38.03%
Low	18.65
Low52	15.75
Low52 Date	2025-05-15
Low52ch	20%
Ma50ch	-4.26%
Price vs 200-day SMA	-10.65%
RSI	44.44
RSI Monthly	39.07
RSI Weekly	42.94
Sharpe ratio	0.27x
Sortino ratio	0.64
Total Return	-2.25%
Tr YTD	0.8
Tr1m	-1.05%
Tr1w	-1.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -43.7M
Operating margin	-5.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,151,267%
Net Borrowing	-26,182,000
Shares Insiders	4.05%
Shares Institutions	9.53%
Shares Out	55,870,950
Shares Qo Q	0.15%
Shares Yo Y	2.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 6.8M
Average Volume	118,789.1x
Bv Per Share	17.69
CAPEX	TWD -47.7M
Ch1m	-1.05
Ch1w	-1.31
Ch1y	11.18
Ch3y	-61.19
Ch5y	-30.37
Ch6m	-24.1
Change	0%
Change From Open	0
Close	18.9
Days Gap	0
Depreciation Amortization	60,414,000
Dollar Volume	1,790,869.5
Earnings Date	2026-05-13
EBIT	TWD -43.7M
EBITDA	TWD 32.5M
EPS	TWD -0.61
F Score	3
FCF	TWD 7.6M
FCF EV Yield	0.52x
FCF Per Share	TWD 0.14
Financing CF	4,342,000
Fiscal Year End	December
Founded	2,003
Goodwill	36,610,000
Income Tax	TWD -10.5M
Investing CF	-55,223,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-06-30
Last Split Date	2021-11-01
Last Split Type	Forward
Ma150	21.23
Ma150ch	-10.98%
Ma20	19.49
Ma20ch	-3.04%
Net CF	4,456,000
Next Earnings Date	2026-05-13
Open	18.9
P FCF Ratio	139
P OCF Ratio	19.08
Position In Range	71.43
Ppne	1,038,999,000
Price Date	2026-05-08
Price EBITDA	TWD 32.48
Ptbv Ratio	1.11
Relative Volume	0.82x
Revenue	843,263,000x
SBC By Revenue	0.09x
Share Based Comp	798,000
Tax By Revenue	-1.24x
Tr6m	-24.1%
Volume	94,755

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6677 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6677 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6677?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.5%

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.3%

Negative means the company is buying back shares.

Technical

TPEX/6677 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.4

Neutral momentum band

Price vs 200-day MA

-10.6%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6677

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6677 stock rating?

tpex/6677 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6677 analysis?

The full report lives at /stocks/tpex/6677/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6677?

The latest report frames tpex/6677 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6677 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.